



The modern diet has seen a drastic reduction in omega-3 fatty acid intake, compounded by a significantly higher intake of omega-6 fatty acids. This is problematic because many of our tissues rely on fatty acids for proper synthesis and communication. If the appropriate fatty acids are not available, the implications for overall health are serious. Ultimately, a relative deficiency in omega-3 fatty acids can lead to a pro-inflammatory state and increase the risk of chronic disease.
The active compounds responsible for the widespread benefits of fish oil supplementation have been identified as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). While both are important for various aspects of human health, EPA is generally considered the anti-inflammatory fatty acid, while DHA is more responsible for neurological development and nerve protection.
EPA and DHA have been clinically studied in a variety of health conditions. For example, supplementation with these omega-3 fatty acids has been shown to benefit cardiovascular health, rheumatoid arthritis, autoimmunity, cognition, mood, skin health, and atopic problems, to name a few clinical indications. Simply put, EPA and DHA should be considered for any systemic inflammatory condition.
One challenge with omega-3 fatty acid supplementation is poor compliance. Most supplements require multiple capsules or teaspoons per day to achieve an evidence-based dose of EPA and DHA. Cyto-Matrix's Peak-EPA solves this problem by providing 700 mg of EPA and 350 mg of DHA in a single capsule. These omega-3 fatty acids, sourced from wild-caught sardines, salmon, and anchovies, are in the well-researched ethyl ester form, allowing for evidence-based, highly concentrated, and cost-effective delivery.
Peak-EPA is molecularly distilled, ensuring purity and the removal of harmful compounds such as heavy metals and organophosphates. Vitamin E is added to the formula to protect and prevent oxidation.
Available in bottles of 90 and 180 capsules.